Volume 13, Number 6—June 2007
Perspective
Economic Evaluation and Catheter-related Bloodstream Infections
Kate Halton*†
and Nicholas Graves*†
and Nicholas Graves*†
Table 1
Inclusion and exclusion criteria for review
| Inclusion criteria |
|---|
| Had a full publication or manuscript for review |
| Conducted a full economic evaluation which valued both costs and benefits of the intervention |
| Based on a decision-analytic model |
| Evaluated at least 1 infection-control intervention aimed at reducing incidence of catheter-related bloodstream infection relative to a baseline scenario |
| Evaluated the intervention with respect to short-term (<21 d), nontunneled, central venous catheters |
| Based in an adult patient population |
| Written in English |
| Exclusion criteria |
| Cost-analysis studies only |
| Did not use a comparator |
| Based on a clinical trial (e.g., randomized controlled trial or pre-post intervention study) or a case study |
| Did not contain an original analysis (e.g., editorials, reviews) |
| Contained purely hypothetical data (e.g., methods articles) |
| Did not provide full details on methods (e.g., letters) |
| Based in a pediatric patient population |
| Evaluated interventions aimed at long-term or tunneled or peripherally placed central venous catheters |
| Evaluated therapeutic or diagnostic interventions, as opposed to preventive interventions |
Page created: July 05, 2010
Page updated: July 05, 2010
Page reviewed: July 05, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.